Understanding Kaposi Sarcoma: A Guide to Diagnosis and Treatment

Receiving a diagnosis of Kaposi sarcoma (KS) can feel overwhelming, but understanding the nature of the disease is the first step toward managing it. This guide is designed to help you navigate your journey and prepare you for detailed discussions with your oncology team.

Overview

Kaposi sarcoma is a type of cancer that develops from the cells that line lymph or blood vessels. It is caused by the human herpesvirus 8 (HHV-8), also known as Kaposi sarcoma-associated herpesvirus (KSHV). While the virus is necessary for the cancer to develop, most people with HHV-8 never develop KS; it typically emerges when the immune system is significantly weakened.

The disease often appears as purple, red or brown lesions on the skin or mucous membranes, such as inside the mouth. However, it can also affect internal organs like the lungs or the digestive tract.

There are four primary types of KS:

• Epidemic (AIDS-related): The most common form in the U.S., occurring in people infected with HIV.
• Classic (Mediterranean): Occurs primarily in older men of Mediterranean, Middle Eastern or Eastern European descent.
• Endemic (African): Found in people living in Equatorial Africa.
• Iatrogenic (Transplant-related): Occurs in people whose immune systems are suppressed following an organ transplant.

Diagnosis

Doctors use several methods to confirm a diagnosis and determine the extent of the disease:

1. Physical Exam and History: A thorough check of the skin and mouth.
2. Biopsy: The most definitive tool. A small sample of a lesion is removed and examined under a microscope.
3. Imaging: Chest X-rays or CT scans may be used to see if the cancer has spread to the lungs or lymph nodes.
4. Endoscopy or Bronchoscopy: If internal KS is suspected, a thin, lighted tube is used to look inside the gastrointestinal tract or airways.

Treatment Options

Treatment is highly individualized and depends on the type of KS, the number of lesions, and the patient’s overall immune health.

Systemic Therapies

• Antiretroviral Therapy (ART): For patients with HIV-associated KS, treating the underlying HIV is the first line of defense. Strengthening the immune system can often cause KS lesions to shrink or disappear.
• Chemotherapy: Drugs like liposomal anthracyclines (doxorubicin or daunorubicin) are used when the disease is widespread or affecting internal organs.
• Immunotherapy: Newer treatments help the immune system recognize and attack the cancer cells.

Local Therapies

If lesions are few and limited to the skin, doctors may use:

• Radiation Therapy: High-energy beams to kill cancer cells.
• Cryotherapy: Freezing the lesions with liquid nitrogen.
• Topical Gels: Applying vitamin A-related drugs (retinoids) directly to the skin.

Adverse Effects

Treatment for KS can involve side effects that vary based on the approach:

Important Note: Some patients may experience Immune Reconstitution Inflammatory Syndrome (IRIS). This happens when the immune system recovers quickly and begins to "attack" the KS, which can temporarily make symptoms look worse before they get better.

Conclusion

A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative effort between your oncologist and other specialists, such as infectious disease experts.

The goal of treatment is to control symptoms, shrink lesions, and maintain a high quality of life. Open communication with your medical team is your most powerful tool.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.